Enhanced targeting specificity to tumor cells by simultaneous recognition of two antigens

Bioconjugate Chemistry

Volumn 11, Issue 4, 2000, Pages 452-460

  Hillairet de Boisferon, Marc ^a   Raguin, Olivier ^a   Dussaillant, Monique ^a   Rostène, William ^a   Barbet, Jacques ^b   Gruaz Guyon, Anne ^a  

^a HÔPITAL SAINT ANTOINE   (France)

^b AIX MARSEILLE UNIVERSITY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODIES; CELLS; CYTOLOGY; INDIUM COMPOUNDS; IRRADIATION; ONCOLOGY; TUMORS;

B CELLS; CELL DIFFERENTIATION; COOPERATIVITY; HAEMATOLOGICAL TUMORS; HIGH DOSE; LYMPHOMA CELLS; NON-HODGKIN LYMPHOMA; RADIOIMMUNOTHERAPY; SPECIFIC SITES; TUMOUR CELLS;

ANTIGENS;

ANIMALIA;

EID: 0011375007     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc9901090     Document Type: Article

References (39)

1. Appelbaum, F. R., Matthews, D, C., Eary, J. F., Badger, C. C., Kellog, M., Press, O. W., Martin, P. J., Fisher, D. R., Nelp, W. B., Donnai Thomas, E., and Bernstein, I. D. (1992) The use of radiolabeled anti-CD33 antibody to augment marrow irradiation prior to marrow transplantation for acute myelogenous leukemia. Transplantation 54 (5), 829-833.
2. Barbet, J., Le Doussal, J. M., Gruaz-Guyon, A., Martin, M., Gautherot, E., and Delaage, M. (1993) Computer simulation of multiple binding equilibrium isotherms: application to the binding of bivalent ligands to antibodies interacting with cell surface Fc-receptors. J. Theor. Biol. 165, 321-340.
3. Barbet, J., Peltier, P., Bardet, S., Vuillez, J. P., Bachelot, I., Denet, S., Olivier, P., Leccia, F., Corcuff, B., Huglo, D., Proye, C., Rouvier, E., Meyer, P., and Chatal, J. F. (1998) Radioimmunodetection of medullary thyroid carcinoma using indium-111 bivalent hapten and anti-CEA × anti-DTPA indium bispecific antibody. J. Nucl. Med. 39, 1172-1178.
4. Barbet, J., Kraeber-Bodéré, F., Vuillez, J. P., Gautherot, E., Rouvier, E., and Chatal, J. F. (1999) Pretargeting with the Affinity Enhancement System for radioimmunotherapy. Cancer. Biother. Radiopharm. 14, 153-166.
5. Bellon, B., Jelsch, J., and Delaage, M. (1973) Théorie des équilibres multiples pour les polymères. Biochimie 55, 1159-1162.
6. 111In-labeled bivalent hapten and a bispecific antibody conjugate. Nucl. Med. Commun. 15, 972-980.
7. Corcoran, M. C., Eary, J., Bernstein, I., and Press, O. W. (1997) Radioimmunotherapy strategies for non-Hodgkin's lymphoma. Ann. Oncol. 8 (Suppl. 1), 133-138.
8. De Labriolle-Vaylet, C., Cattan, P., Sarfati, E., Wioland, M., Billotey, C., Brocheriou, C., Rouvier, E., De Rocquancourt, A., Rostène, W., Askienazy, S., Barbet, J., Milhaud, G., and Gruaz-Guyon, A. (2000) Successful surgical removal of occult metastases of medullary thyroïd carcinoma recurrences with the help of immunoscintigraphy and radioimmunoguided surgery. Clin. Canc. Res. 6 (2), 363-371.
9. DeNardo, G. L., Lewis, J. P., DeNardo, S. J., and O'Grady, L. F. (1994) Effect of Lym-1 radioimmunoconjugate on refractory chronic lymphocytic leukemia. Cancer 73 (5), 1425-1432.
10. 67Cu-2IT-BAT-Lym-1 and opportunities for improvement. In Cancer Therapy with radiolabeled antibodies (D. M. Goldenberg, Ed.) pp 217-227, CRC Press, Inc., Boca Raton, FL.
11. Dower, S. K., DeLisi, C., Titus, J. A., and Segal, D. M. (1981) Mechanism of binding of multivalent immune complexes to Fc receptors. 1. Equilibrium binding. Biochemistry 20, 6326-6334.
12. Gautherot, E., Bouhou, J., Le Doussal, J. M., Manetti, C., Martin, M., Rouvier, E., and Barbet, J. (1997) Therapy for colon carcinoma xenografts with bispecific antibody-targeted, iodine-131-labeled bivalent hapten. Cancer 80, 2618-2623.
13. 2 antibody containing thioether-linked Fab′γ fragments. J. Immunol. 139, 2367-2375.
14. Goldenberg, D. M., Horowitz, J. A., Sharkey, R. M., Hall, T. C., Murthy, S., Goldenberg, H., Lee, R. E., Stein, R., Siegel, J. A., Izon, D. O., Burger, K., Swayne, L. C., Belisle, E., Hansen, H. J., and Pinsky, C. M. (1991) Targeting, dosimetry, and radioimmunotherapy of B-cell lymphomas with iodine-131-labeled LL2 monoclonal antibody. J. Clin. Oncol. 9, 548-564.
15. 1. II. Binding of human IgG subclass proteins and their proteolytic fragments. J. Immunol. 123 (5), 1914-1918.
16. Hillairet de Boisferon, M., Manetti, C., Raguin, O., Gautherot, E., Rostène, W., Barbet, J., and Gruaz-Guyon, A. (1997) Pretargeted radioimmunotherapy using iodine-131-labeled bivalent hapten-bearing peptides. LIPS 4, 331-339.
17. Janevik-Ivanovska, E., Gautherot, E., Hillairet de Boisferon, M., Cohen, M., Milhaud, G., Tartar, A., Rostène, W., Barbet, J., and Gruaz-Guyon, A. (1997) Bivalent hapten-bearing peptides designed for iodine-131 pretargeted radioimmunotherapy. Bioconjugate Chem. 8 (4), 526-533.
18. Jurcic, J. G., Caron, P. C., Nikula, T. K., Papadopoulos, E. B., Finn, R. D., Gansow, O. A., Miller, W. H., Jr., Geerlings, M. W., Warrell, R. P., Jr., Larson, S. M., and Scheinberg, D. A. (1995) Radiolabeled anti-CD33 monoclonal antibody M195 for myeloid leukemia. Cancer Res. 55 (Suppl. 23), 5908-5910.
19. Juweid, M., Sharkey, R. M., Markowitz, A., Behr, T., Swayne, L. C., Dunn, R., Hansen, H. J., Shevitz, J., Leung, S. O., and Rubin, A. D. (1995) Treatment of non-Hodgkin's lymphoma with radiolabeled murine, chimeric, or humanized LL2, an anti-CD22 monoclonal antibody. Cancer Res. 55 (Suppl. 23), 5899s-5907s.
20. Kaminski, M. S., Fig, L. M., Zasadny, K. R., Koral, K. F., DelRosario, R. B., Francis, I. R., Hanson, C. A., Normolle, D. P., Mudgett, E., Liu, C. P., Moon, S., Scott, P., Miller, R. A., and Wahl, R. L. (1992) Imaging, dosimetry, and radioimmunotherapy with iodine 131-labeled anti-CD37 antibody in B-cell lymphoma. J. Clin. Oncol. 10, 1696-1711.
21. Kaminski, M. S., Zasadny, K. R., Francis, I. R., Milik, A. W., Ross, C. W., Moon, S. D., Crawford, S. M., Burgess, J. M., Petry, N. A., Butchko, G. M., Glenn, S. D., and Wahl, R. L. (1993) Radioimmunotherapy of B-cell lymphoma with [131I]anti-B1 (anti-CD20) antibody. N. Engl. J. Med. 329, 459-465.
22. Kaminski, M. S., Zasadny, K. R., Francis, I. R., Fenner, M. C, Ross, C. W., Milik, A. W., Estes, J., Tuck, M., Regan, D., Fisher, S., Glenn, S. D. and Wahl, R. L. (1996) Iodine-131-anti-B1 radioimmunotherapy for B-cell lymphoma. J. Clin. Oncol. 14 (7), 1974-1981.
23. Knox, S. J., Goris, M. L., Trisler, K., Negrin, R., Davis, T., Liles, T. M., Grillo-López, A., Chinn, P., Varns, C., Ning, S. C., Fowler, S., Deb, N., Becker, M., Marquez, C., and Levy, R. (1996) Yttrium-90-labeled anti-CD20 monoclonal antibody therapy of recurrent B-cell lymphoma. Clin. Cancer Res. 2, 457-470.
24. Köhler, G., and Milstein, C. (1975) Continuous cultures of fused secreting antibody of redefined specificity. Nature 256, 495-497.
25. Koren, H. S., Handwerger, B. S., and Wunderlich, J. R. (1975) Identification of macrophage-like characteristics in a cultured murine tumor line. J. Immunol. 114, 894-897.
26. Le Doussal, J. M., Gruaz-Guyon, A., Martin, M., Gautherot, E., Delaage, M., and Barbet, J. (1990) Targeting of indium 111-labeled bivalent hapten to human melanoma mediated by bispecific monoclonal antibody conjugates: imaging of tumors hosted in nude mice. Cancer Res, 50, 3445-3452.
27. Le Doussal, J. M., Gautherot, E., Martin, M., Barbet, J., and Delaage, M. (1991) Enhanced in vivo targeting of an asymmetric bivalent hapten to double-antigen-positive mouse B-cells with monoclonal antibody conjugate cocktails. J. Immunol. 146, 169-175.
28. Le Doussal, J. M., Chetanneau, A., Gruaz-Guyon, A., Martin, M., Gautherot, E., Lehur, P. A., Chatal, J. F., Delaage, M., and Barbet, J. (1993) Bispecific monoclonal antibody-mediated targeting of an indium-111-labeled DTPA dimer to primary colorectal tumors: pharmacokinetics, biodistribution, scintigraphy and immune response. J. Nucl. Med. 34, 1662-1671.
29. Liu, S. Y., Eary, J. F., Petersdorf, S. H., Martin, P. J., Maloney, D. G., Appelbaum, F. R., Matthews, D. C., Bush, S. A., Durack, L. D., Fisher, D. R., Gooley, T. A., Bernstein, I. D., and Press, O. W. (1998) Follow-up of relapsed B-cell lymphoma patients treated with iodine-131-labeled anti-CD20 antibody and autologous stem-cell rescue. J. Clin. Oncol. 16, 3270-3278.
30. 1 lymphoma with anti-idiotype antibodies: biodistribution kinetics of directly labeled antibodies and bispecific antibody-targeted bivalent haptens. Int. J. Cancer 71, 1000-1009.
31. 131I-labeled anti-CD45 antibody, combined with cyclophosphamide and total body irradiation. Blood 85 (4), 1122-1131.
32. Morel, A., Darmon, M., and Delaage, M. (1990) Recognition of imidazole and histamine derivatives by monoclonal antibodies. Mol. Immunol. 27, 995-1000.
33. Press, O. W., Eary, J. F., Appelbaum, F. R., Martin, P. J., Badger, C. C., Nelp, W. B., Glenn, S., Butchko, G., Fisher, D. R., Porter, B., Matthews, D. C., Fisher, L. D., and Bernstein, I. D. (1993) Radiolabeled-antibody therapy of B-cell lymphoma with autologous bone marrow support. N. Engl. J. Med. 329, 1219-1224.
34. 131I-B1 (anti-CD20) antibody therapy with autologous stem cell transplantation for relapsed B-cell lymphomas. Lancet 346, 336-340.
35. Salacinsky, P. R., McLean, C., Sykes, J. E., Clement-Jones, V. V., and Lowry, P. J. (1981) Iodination of proteins and peptides using a solid-phase oxidizing agent 1,3,4,6-tetrachloro-3,6-diphenylglycoluryl (iodogen). Anal. Biochem. 117, 136-146.
36. Scheinberg, D. A., Lovett, D., Divgi, C. R., Graham, M. C., Berman, E., Pentlow, K., Feirt, N., Finn, R. D., Clarkson, B. D., Gee, T. S., Larson, S. M., Oettgen, H. F., and Old, L. J. (1991) A phase I trial of monoclonal antibody M195 in acute myelogenous leukemia: specific bone marrow targeting and internalization of radionuclide. J. Clin. Oncol. 9, 478-490.
37. Vuillez, J. P., Moro, D., Brichon, P. Y., Rouvier, E., Brambilla, E., Barbet, J., Peltier, P., Meyer, P., Sarrazin, R., and Brambilla, C. (1997) Two-step immunoscintigraphy for nonsmall-cell lung cancer staging using a bispecific anti-CEA/ anti-indium-DTPA antibody and an indium-111-labeled DTPA dimer. J. Nucl. Med. 38, 507-511.
38. Waldmann, T. A. (1994) Lymphokine receptors: a target for immunotherapy of lymphomas. Ann. Oncol. 5 (Suppl. 1), 13-17.
39. Wilder, R. B., DeNardo, G. L., and DeNardo, S. J. (1996) Radioimmunotherapy: recent results and future directions. J. Clin. Oncol. 14, 1383-1400.